Genelux Corp. (GNLX)
2.00
+0.02
(+1.01%)
USD |
NASDAQ |
Oct 23, 16:00
2.09
+0.09
(+4.50%)
After-Hours: 20:00
Genelux Price : 2.00 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 2.02 | 2.07 | 1.90 | 2.00 | 648745.0 |
| Oct 22, 2026 | 2.04 | 2.35 | 1.96 | 1.98 | 947444.0 |
| Oct 21, 2026 | 2.53 | 2.57 | 2.018 | 2.07 | 850725.0 |
| Oct 20, 2026 | 2.43 | 2.612 | 2.43 | 2.50 | 331726.0 |
| Oct 19, 2026 | 2.42 | 2.470 | 2.40 | 2.45 | 161491.0 |
| Oct 16, 2026 | 2.48 | 2.520 | 2.355 | 2.42 | 277873.0 |
| Oct 15, 2026 | 2.40 | 2.51 | 2.33 | 2.48 | 796527.0 |
| Oct 14, 2026 | 2.48 | 2.52 | 2.32 | 2.32 | 410559.0 |
| Oct 13, 2026 | 2.53 | 2.54 | 2.485 | 2.52 | 151876.0 |
| Oct 12, 2026 | 2.59 | 2.59 | 2.51 | 2.545 | 72617.00 |
| Oct 09, 2026 | 2.48 | 2.57 | 2.47 | 2.56 | 154650.0 |
| Oct 08, 2026 | 2.47 | 2.53 | 2.42 | 2.50 | 259115.0 |
| Oct 07, 2026 | 2.52 | 2.59 | 2.46 | 2.52 | 550980.0 |
| Oct 06, 2026 | 2.58 | 2.63 | 2.52 | 2.54 | 77648.00 |
| Oct 05, 2026 | 2.55 | 2.66 | 2.465 | 2.60 | 317345.0 |
| Oct 02, 2026 | 2.55 | 2.59 | 2.515 | 2.56 | 278256.0 |
| Oct 01, 2026 | 2.53 | 2.56 | 2.46 | 2.52 | 200938.0 |
| Sep 30, 2026 | 2.47 | 2.55 | 2.47 | 2.53 | 236871.0 |
| Sep 29, 2026 | 2.48 | 2.56 | 2.415 | 2.45 | 164898.0 |
| Sep 28, 2026 | 2.46 | 2.50 | 2.41 | 2.47 | 103751.0 |
| Sep 25, 2026 | 2.47 | 2.54 | 2.420 | 2.48 | 139874.0 |
| Sep 24, 2026 | 2.51 | 2.524 | 2.41 | 2.43 | 151994.0 |
| Sep 23, 2026 | 2.61 | 2.640 | 2.50 | 2.515 | 115793.0 |
| Sep 22, 2026 | 2.55 | 2.630 | 2.52 | 2.61 | 161803.0 |
| Sep 21, 2026 | 2.57 | 2.585 | 2.51 | 2.56 | 197287.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.53 |
Price Related Metrics
| PS Ratio | 10294.34 |
| PEG Ratio | -1.779 |
| Price to Book Value | 5.598 |
| Earnings Yield | -43.40% |
| Market Cap | 90.21M |
| PEGY Ratio | -1.779 |